Home › Therapeutic areas › Oncology › Gastric Cancer
Gastric Cancer (9 companies)
Companies with an active program in Gastric Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics | ImmunologyOncology Rare | 1 | Phase 2 | 10 |
| ARTV | Artiva Biotherapeutics | DermatologyImmunology+2 Rare | 1 | Phase 2 | 14 |
| CGEN | Compugen | Oncology | 1 | Phase 3 | 7 |
| CBIO | Crescent Biopharma | Oncology | 1 | Phase 2 | 10 |
| CTMX | CytomX Therapeutics | Oncology | 1 | Phase 1 | 6 |
| LEGN | Legend Biotech | Oncology Rare | 1 | Approved | 8 |
| INKT | MiNK Therapeutics | ImmunologyOncology+1 Rare | 1 | Phase 2 | 7 |
| NBP | NovaBridge Biosciences | OncologyOphthalmology | 1 | Phase 2 | 6 |
| XNCR | Xencor | HematologyImmunology+4 Rare | 1 | Approved | 36 |
No companies match.